Pretransplant Bridging With Blinatumomab Reduces MRD in Children With B-Cell Acute Lymphocytic Leukemia
In a study of children with B-cell acute lymphocytic leukemia (B-ALL) who are about to undergo allogeneic hematopoietic cell transplantation (alloHCT), bridging with blinatumomab...
Pegylated Interferon Leads to High Response Rates in Essential Thrombocythemia and Polycythemia Vera After...
According to results of a phase II study published in Blood, treatment with pegylated-interferon-α (PEG-rIFN-α) was associated with an overall response rate (ORR) of...
FDA Approves Ferric Maltol for Treatment of Iron Deficiency
The U.S. Food and Drug Administration (FDA) announced its approval of oral ferric maltol for the treatment of iron deficiency in adults.
Ferric maltol is...
Clofarabine Plus Cytarabine May Provide Less Toxic Option for Newly Diagnosed Pediatric Patients With...
For children newly diagnosed with acute myeloid leukemia (AML), treatment with a combination of clofarabine plus cytarabine was associated with similar survival rates when...
ASH Clinical News Now Available on the ASH Publications App, ABIM Changing Maintenance of...
ASH Clinical News Now Available on the ASH Publications App
The American Society of Hematology (ASH) Publications app provides access to content from Blood, Blood...
Rivipansel Fails to Meet Phase III Trial Endpoints
In a pivotal phase III trial, rivipansel failed to meet its primary and secondary efficacy endpoints in patients with sickle cell disease (SCD) who...
Can ICH Survivors Safely RESTART Antiplatelet Therapy?
While treatment with antiplatelet therapy lessens the risks of subsequent occlusive vascular events, it may increase the risk of recurrent intracerebral hemorrhage (ICH) in...
Roxadustat Improves Hemoglobin Levels and Response Rates in Patients With Anemia Related to Chronic...
According to results from a phase III trial, roxadustat increased hemoglobin levels and hemoglobin response rates, compared with placebo, in patients with anemia and...
Genetic Testing and Drug Companies Partner to Develop New Medicines
Since its launch, 23andMe has provided more than 8 million customers with information about their ancestry and predisposition to developing certain diseases. Now, a...
Remembering Stanley Schrier, John Hansen, and more
Remembering Stanley Schrier (1929 – 2019)
Stanley Schrier, MD, a former American Society of Hematology (ASH) president who spent nearly 60 years at Stanford University’s...
Current Issue
October 2019, Volume 5, Issue 12
This issue highlights the unintended consequences of fighting the nation’s opioid epidemic, considers the optimal frontline regimen for myeloma, and more.
